A Tavridou

Summary

Affiliation: Democritus University of Thrace
Country: Greece

Publications

  1. doi The association of adipokine levels in plasma and synovial fluid with the severity of knee osteoarthritis
    Christos Staikos
    Academic Department of Orthopaedics, Medical School, Democritus University of Thrace, Dragana Campus, 68100 Alexandroupolis, Greece
    Rheumatology (Oxford) 52:1077-83. 2013
  2. doi Association of VKORC1 -1639 G>A polymorphism with carotid intima-media thickness in type 2 diabetes mellitus
    Anna Tavridou
    Lab of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, 68100 Alexandroupolis, Greece
    Diabetes Res Clin Pract 94:236-41. 2011
  3. ncbi Emerging targets for the treatment of dyslipidemia
    A Tavridou
    Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, Alexandroupolis, Greece
    Curr Med Chem 18:909-22. 2011
  4. doi Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia
    Anna Tavridou
    Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, 68100 Alexandroupolis, Greece
    Heart Vessels 25:288-93. 2010
  5. ncbi EP2300 compounds: focusing on the antiatherosclerotic properties of squalene synthase inhibitors
    A Tavridou
    Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece
    Curr Pharm Des 15:3167-78. 2009
  6. doi Inhibitors of 5-lipoxygenase activating protein: WO 2008/030369
    Anna Tavridou
    Lab of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, Alexandroupolis, Greece
    Expert Opin Ther Pat 19:1473-6. 2009
  7. doi Thr54 allele of fatty-acid binding protein 2 gene is associated with obesity but not type 2 diabetes mellitus in a Caucasian population
    A Tavridou
    Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, 68100 Alexandroupolis, Greece
    Diabetes Res Clin Pract 84:132-7. 2009
  8. ncbi Novel molecules targeting dyslipidemia and atherosclerosis
    A Tavridou
    Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis 68100, Greece
    Curr Med Chem 15:792-802. 2008
  9. ncbi Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease
    A Tavridou
    Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, 68100, Alexandroupolis, Greece
    Eur J Clin Pharmacol 62:485-9. 2006
  10. ncbi Predictors of lipoprotein(a) levels in a European and South Asian population in the Newcastle Heart Project
    A Tavridou
    Department of Pharmacology, ELPEN Pharmaceutical Co Inc, Pikermi, Attika, Greece
    Eur J Clin Invest 33:686-92. 2003

Collaborators

Detail Information

Publications10

  1. doi The association of adipokine levels in plasma and synovial fluid with the severity of knee osteoarthritis
    Christos Staikos
    Academic Department of Orthopaedics, Medical School, Democritus University of Thrace, Dragana Campus, 68100 Alexandroupolis, Greece
    Rheumatology (Oxford) 52:1077-83. 2013
    ..We sought to determine the association between plasma and SF levels of leptin and adiponectin in patients with knee OA...
  2. doi Association of VKORC1 -1639 G>A polymorphism with carotid intima-media thickness in type 2 diabetes mellitus
    Anna Tavridou
    Lab of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, 68100 Alexandroupolis, Greece
    Diabetes Res Clin Pract 94:236-41. 2011
    ..We examined a potential association between VKORC1 -1639 G>A polymorphism and T2DM and, also, the association of this polymorphism with carotid intima-media thickness (cIMT)...
  3. ncbi Emerging targets for the treatment of dyslipidemia
    A Tavridou
    Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, Alexandroupolis, Greece
    Curr Med Chem 18:909-22. 2011
    ..In conclusion, the emergence of agents that act in monotherapy or in combination with available lipid-modifying drugs may allow more effective management of dyslipidemia and, consequently, reduce the burden of CVD...
  4. doi Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia
    Anna Tavridou
    Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, 68100 Alexandroupolis, Greece
    Heart Vessels 25:288-93. 2010
    ..Simvastatin significantly reduced circulating ox-LDL in both groups, but whether this reduction is related to clinical outcomes remains to be shown...
  5. ncbi EP2300 compounds: focusing on the antiatherosclerotic properties of squalene synthase inhibitors
    A Tavridou
    Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece
    Curr Pharm Des 15:3167-78. 2009
    ..The satisfactory safety profile of EP2300 compounds in this animal model is a promising finding in view of future clinical studies...
  6. doi Inhibitors of 5-lipoxygenase activating protein: WO 2008/030369
    Anna Tavridou
    Lab of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, Alexandroupolis, Greece
    Expert Opin Ther Pat 19:1473-6. 2009
    ..Development of FLAP inhibitors has attracted considerable attention in recent years owing to genetic data supporting their potential as a valid pharmacological approach in prevention or treatment of atherosclerotic disease...
  7. doi Thr54 allele of fatty-acid binding protein 2 gene is associated with obesity but not type 2 diabetes mellitus in a Caucasian population
    A Tavridou
    Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, 68100 Alexandroupolis, Greece
    Diabetes Res Clin Pract 84:132-7. 2009
    ..Our aim was to investigate possible associations of FABP2 A54T polymorphism with T2DM and/or obesity in a Greek Caucasian population...
  8. ncbi Novel molecules targeting dyslipidemia and atherosclerosis
    A Tavridou
    Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis 68100, Greece
    Curr Med Chem 15:792-802. 2008
    ..In conclusion, there are several promising novel therapeutic approaches for dyslipidemia and atherosclerosis under development which are expected to be of great benefit for patients at risk of CVD...
  9. ncbi Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease
    A Tavridou
    Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, 68100, Alexandroupolis, Greece
    Eur J Clin Pharmacol 62:485-9. 2006
    ....
  10. ncbi Predictors of lipoprotein(a) levels in a European and South Asian population in the Newcastle Heart Project
    A Tavridou
    Department of Pharmacology, ELPEN Pharmaceutical Co Inc, Pikermi, Attika, Greece
    Eur J Clin Invest 33:686-92. 2003
    ..Understanding of the higher susceptibility of South Asians to coronary heart disease is limited. One explanation is the combination of high prevalence of insulin resistance with higher lipoprotein(a) levels...